LV11596A - Ilgstosas darbibas injekciju suspensijas un metode to sagatavosanai - Google Patents

Ilgstosas darbibas injekciju suspensijas un metode to sagatavosanai

Info

Publication number
LV11596A
LV11596A LV960226A LV960226A LV11596A LV 11596 A LV11596 A LV 11596A LV 960226 A LV960226 A LV 960226A LV 960226 A LV960226 A LV 960226A LV 11596 A LV11596 A LV 11596A
Authority
LV
Latvia
Prior art keywords
preparation
long
injection suspensions
acting injection
acting
Prior art date
Application number
LV960226A
Other languages
English (en)
Other versions
LV11596B (en
Inventor
Juergen Engel
Karin Klokkers-Bethke
Thomas Reissman
Peter Hilgard
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/661,017 external-priority patent/US5773032A/en
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of LV11596A publication Critical patent/LV11596A/lv
Publication of LV11596B publication Critical patent/LV11596B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
LVP-96-226A 1993-12-09 1996-07-09 Long-acting injection susoensions and a process for their preparation LV11596B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4342092A DE4342092B4 (de) 1993-12-09 1993-12-09 Langwirkende Injektionssuspension und Verfahren zur Herstellung
PCT/EP1994/003904 WO1995015767A1 (en) 1993-12-09 1994-11-25 Long-acting injection suspensions and a process for their preparation
US08/661,017 US5773032A (en) 1993-12-09 1996-06-10 Long-acting injection suspensions and a process for their preparation

Publications (2)

Publication Number Publication Date
LV11596A true LV11596A (lv) 1996-12-20
LV11596B LV11596B (en) 1997-06-20

Family

ID=25931926

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-96-226A LV11596B (en) 1993-12-09 1996-07-09 Long-acting injection susoensions and a process for their preparation

Country Status (27)

Country Link
EP (1) EP0732934B1 (lv)
JP (1) JPH09509145A (lv)
CN (2) CN1248732C (lv)
AT (1) ATE310530T1 (lv)
AU (1) AU677748B2 (lv)
BR (1) BR9408272A (lv)
CZ (1) CZ291025B6 (lv)
DE (1) DE4342092B4 (lv)
DK (1) DK0732934T3 (lv)
EE (1) EE03224B1 (lv)
EG (1) EG20787A (lv)
ES (1) ES2251715T3 (lv)
FI (1) FI116121B (lv)
HK (1) HK1063746A1 (lv)
HR (1) HRP940978B1 (lv)
HU (1) HU217081B (lv)
IL (1) IL111928A (lv)
LV (1) LV11596B (lv)
NO (1) NO318984B1 (lv)
NZ (1) NZ277239A (lv)
PL (1) PL186929B1 (lv)
RO (1) RO119343B1 (lv)
RS (1) RS49511B (lv)
RU (1) RU2152222C1 (lv)
SK (2) SK284980B6 (lv)
WO (1) WO1995015767A1 (lv)
ZA (1) ZA949798B (lv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
SI0732934T1 (sl) * 1993-12-09 2006-02-28 Zentaris Gmbh Dolgo delujoce injekcijske suspenzije LHRH analoga in postopek njihove izdelave
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
DE10040700A1 (de) * 2000-08-17 2002-02-28 Asta Medica Ag Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
WO2002047722A1 (fr) * 2000-12-15 2002-06-20 Takeda Chemical Industries, Ltd. Compositions medicinales agoniste ou antagoniste de la gonadoliberine non peptidyl, methode de production et utilisation desdites compositions
TW200526267A (en) * 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
US7098305B2 (en) 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
BRPI0720582B1 (pt) 2006-12-18 2021-08-24 Takeda Pharmaceutical Company Limited Composição de liberação prolongada, processo para a preparação da mesma, composição farmacêutica, agente profilático ou terapêutico, e, uso de uma substância fisiologicamente ativa
ES2654147T3 (es) * 2009-11-16 2018-02-12 Ipsen Pharma S.A.S. Composiciones farmacéuticas de ligandos del receptor de melanocortina
CN102504018A (zh) * 2011-10-28 2012-06-20 沈阳药科大学 可持续释放的蜂毒肽帕莫酸盐及其制剂
CA3018402C (en) * 2016-03-29 2021-05-11 Shanghai Synergy Pharmaceutical Sciences Co., Ltd Vortioxetine pamoic acid salt and crystal form thereof
CN108969478A (zh) * 2018-08-29 2018-12-11 江南大学 一种美金刚难溶盐缓释注射剂及其制备方法
CN110003195B (zh) * 2019-05-21 2020-05-26 湖北中医药大学 鲁拉西酮晶体及其制备方法和在注射给药系统中的应用
CN112569340A (zh) * 2020-12-31 2021-03-30 苏州素仕生物科技有限公司 一种无菌布舍瑞林注射液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852422A (en) * 1971-06-26 1974-12-03 Serono Ist Farm Long-active gonadotropins
NZ181036A (en) * 1975-06-12 1978-12-18 A Schally Luteinising hormone releasing hormone analogues and intermediates therefor
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
FR2647677B1 (fr) * 1989-05-31 1991-09-27 Roussel Uclaf Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
CH679207A5 (lv) * 1989-07-28 1992-01-15 Debiopharm Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.

Also Published As

Publication number Publication date
HUT75712A (en) 1997-05-28
DE4342092A1 (de) 1995-06-14
NO961877D0 (no) 1996-05-09
HRP940978A2 (en) 1997-02-28
FI962354A0 (fi) 1996-06-06
AU1219995A (en) 1995-06-27
RU2152222C1 (ru) 2000-07-10
IL111928A0 (en) 1995-03-15
ES2251715T3 (es) 2006-05-01
IL111928A (en) 1999-11-30
RO119343B1 (ro) 2004-08-30
NO318984B1 (no) 2005-05-30
PL186929B1 (pl) 2004-04-30
CN1136916C (zh) 2004-02-04
DK0732934T3 (da) 2006-03-27
HRP940978B1 (en) 2006-08-31
EG20787A (en) 2000-02-29
CN1136779A (zh) 1996-11-27
EE03224B1 (et) 1999-10-15
EP0732934B1 (en) 2005-11-23
ATE310530T1 (de) 2005-12-15
SK284980B6 (sk) 2006-03-02
BR9408272A (pt) 1996-12-17
ZA949798B (en) 1995-08-18
CN1248732C (zh) 2006-04-05
JPH09509145A (ja) 1997-09-16
AU677748B2 (en) 1997-05-01
RS49511B (sr) 2006-10-27
YU72194A (sh) 1997-03-07
PL314913A1 (en) 1996-09-30
EP0732934A1 (en) 1996-09-25
HK1063746A1 (en) 2005-01-14
FI116121B (fi) 2005-09-30
FI962354A (fi) 1996-06-06
LV11596B (en) 1997-06-20
SK284981B6 (sk) 2006-03-02
CZ291025B6 (cs) 2002-12-11
HU217081B (hu) 1999-11-29
WO1995015767A1 (en) 1995-06-15
CN1494919A (zh) 2004-05-12
NO961877L (no) 1996-05-09
CZ142096A3 (en) 1996-12-11
SK66796A3 (en) 1997-08-06
HU9601584D0 (en) 1996-08-28
NZ277239A (en) 1997-03-24
DE4342092B4 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
LV11596A (lv) Ilgstosas darbibas injekciju suspensijas un metode to sagatavosanai
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
BG101781A (en) Active substance-containing solid preparation
AU8418891A (en) Novel polyamines and method for preparation thereof
CA2178592A1 (en) Long-acting injection suspensions and a process for their preparation
ATE203411T1 (de) Lagerstabile wässrige pharmazeutische zubereitungen von g-csf
IT1304152B1 (it) Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
DK2016950T3 (da) Farmaceutisk sammensætning omfattende et exendin-4-peptid
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
WO1998017319A3 (en) Platelet substitutes and conjugation methods suitable for their preparation
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
IT1230703B (it) Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
DE69301093D1 (de) Boulekugel sowie verfahren zu deren herstellung
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
TW357060B (en) Sea urchin feed
MY119896A (en) Long-acting injection suspensions and a process for their preparation.
BG102514A (en) New lh-rh-antagonists of improved effect